Sep 3, 2021
Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced that a tolerability and pharmacokinetic study, performed by an independent, premier animal testing laboratory in the U.S., had demonstrated that administration of colchicine using its proprietary DehydraTECH(TM) resulted in increased delivery. “Colchicine is an approved therapeutic with anti-inflammatory effects primarily used to treat gout and cardiac conditions such as pericarditis. It was the latest of several drugs Lexaria tested with known SARS-CoV-2/COVID-19 antiviral properties after it showed potent effects in mitigating the cytokine storm associated with the virus. Additionally, colchicine is occasionally used to treat emergent pericarditis in children, which would make the substance potentially beneficial against this form of cardiac inflammation when it occurs as a side effect of mRNA COVID-19 vaccines,” reads a recent article. As colchicine has a marginal difference between toxic and non-toxic doses, Lexaria hopes that by using DehydraTECH, it can improve the drug’s bioavailability beyond current levels of approximately 45%, which would potentially allow lower dosing requirements. “Lexaria’s DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery. The method has been evaluated thoroughly through in vivo, in vitro and human clinical testing. The company has shown, through animal studies, that DehydraTECH technology elevates the quantity of drugs delivered across the blood-brain barrier by as much as 1,900%. The research has initiated new patent applications and opened the possibilities for improved drug delivery.”
To view the full article, visit https://cnw.fm/enI8j
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp.’s proprietary drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The company’s technology can be applied to many different ingestible product formats, including foods, beverages, oral suspensions, tablets, and capsules. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes. It is planned to be further evaluated for orally administered bioactive molecules, including anti-viral drugs, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and more. Lexaria has licensed DehydraTECH to multiple companies including a world-leading tobacco producer for the development of smokeless, oral-based nicotine products and for use in industries that produce cannabinoid beverages, edibles and oral products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 20 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]
CannabisNewsWire is part of the InvestorBrandNetwork.
New York’s Times Square hardly lacks visual stimulation. Yet for the unveiling of GucciCore, the house’s cruise 2027 collection, it chose the district’s relentless digital glow as its backdrop, treating one of the city’s loudest landmarks as the stage for a collection with everyday roots: looks that might be encountered on the streets. Before the show, Gucci filled Times Square’s screens with a montage of found footage and mock advertisements spanning Gucci Automobili, Gucci Gym, Gucci Pets and...
"If you're in a major situation, just scream, 'Fire, fire, my child's inside,' or something extremely dramatic. I was viciously attacked by a dog in my backyard ... I was screaming, 'Help me, I'm going to die,' and NO ONE HELPED." View Entire Post ›
While clout and trendiness may be the currency of contemporary fashion, Hong Kong costume designer-turned-jewellery artist Vann Kwok chooses to prioritise artistic narrative over social capital or seasonal hype. Kwok founded Vann Jewellery in 2019 “to create something cool and fashionable, but now, I’m a middle-aged woman”, she quips. “Being cool isn’t essential to me any more; it’s not something I feel compelled to achieve. “If people find my work cool, thank you – but it’s really a platform...
A brand of turkey gravy sold in Canada has been recalled because it contains undeclared mustard.
Hong Kong’s Asia+ Festival, the annual celebration of the cultural diversity of the region, particularly those countries linked by the Belt and Road Initiative – China’s plan to develop a global trading network – is back for its fourth edition under the theme “Traditions Recast”. Two headline shows at this year’s festival – organised by the Leisure and Cultural Services Department – which runs until the end of November, perfectly capture that spirit by fusing ancient music with visual art and...
As part of its strategic efforts to diversify tourism source markets and expand its international reach, the Ajman Department of Tourism, Culture and Media is conducting a promotional roadshow across Central Asia from 12 to 16 October, with dedicated events in Tashkent on 13 October and Almaty on 15 October. The roadshow aims to strengthen direct engagement with key travel and tourism partners, showcase Ajman’s diverse destination offering, and explore new opportunities for cooperation and strategic partnerships across two promising markets. The initiative also supports the Department’s wider efforts to broaden its international partner network and strengthen Ajman’s visibility among new visitor segments.
I couldn't even recognize the ingredients for some of these... View Entire Post ›
In the last instalment of a four-part Health Matters series on traditional Chinese medicine, Chloe Loung experiences the patient journey at Hong Kong’s new Chinese medicine hospital, where Western doctors and TCM practitioners work side by side to streamline holistic healthcare. There are no receptionists barking ticket numbers in chaotic waiting rooms at the new Chinese Medicine Hospital of Hong Kong. In fact, stepping into the complex’s sunlit atrium, you can barely hear a footstep. Hong...
Archie Renaux stars as the ambitious lawyer Johnny Warren in HBO’s latest legal drama War. Starring Renaux, Sienna Miller and Dominic West, the anthology premiered on October 1. Its first season follows the high-profile and multimillion dollar divorce between social media mogul Morgan Henderson (West) and his film star wife Carla Duval (Miller). The show also follows the estranged couple’s attorneys from rival law firms Cathcarts & Sons and Taylor & Byrne. Renaux’s character, Johnny, becomes...
Hong Kong milk tea – a mainstay of cha chaan teng, or Hong Kong-style diners – is taking on a new role in Tokyo’s cafe culture. According to the Japan Tea Association, the country is in the midst of a “third black tea boom” and more cafes are offering black tea menus. Even convenience stores are revamping their takeaway drink options, with 7-Eleven, for example, expanding its Seven Cafe tea machines to around 2,000 stores in early 2026. Suntory also released a Hong Kong-style milk tea under its...
Fliggy, a leading online travel platform and wholly owned subsidiary of Alibaba Group has released travel booking data and trends for the 2026 Mid-Autumn Festival and National Day Holiday, highlighting record hotel demand, rising interest in immersive travel experiences, and growing adoption of AI-powered travel services among Chinese travelers.
Lead cast: Ji Chang-wook, Mio Imada Cross-cultural media ties between Japan and South Korea continue to blossom with Merry Berry Love, a rural romance starring Ji Chang-wook (The Worst of Evil) and Mio Imada (Trillion Game). Co-produced by South Korea’s CJ ENM and Japan’s Nippon Television, the show airs locally on Nippon TV and streams globally on Disney+. Although written and directed by South Korean creatives, the story unfolds largely on Charo Island, in rural Japan. Imada plays Karin...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.